Aardvark Therapeutics, Inc.
AARD
$8.22
-$0.30-3.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.66M | 82.36M | 86.35M | 86.35M | 9.99M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 314.00K | 170.00K | 445.00K | 445.00K | 252.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 160.00K | 136.00K | 197.00K | 197.00K | 127.00K |
| Total Current Assets | 74.14M | 82.67M | 86.99M | 86.99M | 10.37M |
|
|
|||||
| Total Current Assets | 74.14M | 82.67M | 86.99M | 86.99M | 10.37M |
| Net Property, Plant & Equipment | 735.00K | 841.00K | 105.00K | 105.00K | 155.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.64M | 232.00K | 108.00K | 108.00K | 13.00K |
| Total Assets | 77.51M | 83.74M | 87.20M | 87.20M | 10.54M |
|
|
|||||
| Total Accounts Payable | 2.30M | 666.00K | 1.22M | 1.22M | 1.04M |
| Total Accrued Expenses | 2.29M | 1.62M | 1.33M | 1.33M | 235.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 338.00K | 323.00K | 108.00K | 108.00K | 112.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.93M | 2.61M | 2.66M | 2.66M | 1.38M |
|
|
|||||
| Total Current Liabilities | 4.93M | 2.61M | 2.66M | 2.66M | 1.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 441.00K | 545.00K | -- | -- | 50.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.00K | -- | -- | -- | 2.00K |
| Total Liabilities | 5.39M | 3.16M | 2.66M | 2.66M | 1.43M |
|
|
|||||
| Common Stock & APIC | 3.68M | 3.37M | 3.06M | 3.06M | 2.94M |
| Retained Earnings | -58.33M | -49.55M | -45.37M | -45.37M | -37.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -54.64M | -46.17M | -42.31M | -42.31M | -34.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 126.76M | 126.76M | 126.85M | 126.85M | 43.90M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 126.76M | 126.76M | 126.85M | 126.85M | 43.90M |
|
|
|||||
| Total Common Equity | -54.64M | -46.17M | -42.31M | -42.31M | -34.80M |
| Total Preferred Equity | 126.76M | 126.76M | 126.85M | 126.85M | 43.90M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 72.11M | 80.58M | 84.54M | 84.54M | 9.10M |
|
|
|||||